Products & Services Technology Customer Support News About Us
 
 
 

Integrated Genomics, Inc. Appoints Jonathan M. Sheridan President, CEO and Member of the Board of Directors

Integrated Genomics, Inc., a provider of bioinformatics products and services for the life sciences industry, has announced it has named Jonathan M. Sheridan to the position of President and Chief Executive Officer, succeeding Dr. John Elling who will remain Chairman of the Board.

Prior to Integrated Genomics, Mr. Sheridan was VP Commercial Operations HTG Inc. where he was responsible for forming new business partnerships with pharmaceutical and life sciences companies, establishing research agreements with academic institutions, and managing the global commercial sales and marketing teams. Mr. Sheridan also held senior positions with PerkinElmer Life and Analytical Sciences, Epicentre Biotechnologies, Genomica, Lion Biosciences, PerkinElmer Cetus, Beckman Coulter, and Monsanto.

“Jonathan Sheridan is a proven executive with an exceptional blend of strategic, business and leadership skills,” said Elling. “We are confident that he is the ideal person to sustain IG’s strong performance and lead the Company in the next phase of its growth.”

“I am excited about the potential that IG presents. Integrated Genomics ERGO™ platform is the leading genomic tool for microbial systems biology and IG is on the verge of becoming the leader in microbial metabolic engineering,” stated Mr. Sheridan.

About Integrated Genomics
Integrated Genomics (www.integratedgenomics.com) is a provider of bioinformatics products and services for the life sciences industry. The company’s expertise in microbial genomics includes genome sequencing, comparative genomics, custom bioinformatics applications and microbial metabolic engineering. IG has developed and distributes ERGO™, the most advanced and comprehensive bioinformatics suite for microbial genomics on the market. ERGO™ contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions representing over 6,000 networked metabolic and non-metabolic pathways.

Contact:
Integrated Genomics
Vinayak Kapatral, Ph.D.
Vice President, Business Development
312-491-0846 x 326
vinayak@integratedgenomics.com

   
 
   
   
 
News
   
  Discover Us
 
  Press Releases

1998

1999

2000

2001

2003

2004

2005

2006

2007

2008

2009
 
  IG Newsletters
 
  IG Publications
 
  New ERGO™ Features
 
  New/Upcoming Genomes
   

 

Home - Legal - Contact us - Site Map Ergo Logo
©2006 Integrated Genomics, All Rights Reserved